Pre-emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pre-emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer

Published:2022-11-28 Issue:11 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Uneno Yu¹,Imura Haruki²,Makuuchi Yosuke³,Tochitani Kentaro⁴,Watanabe Norio⁵

Affiliation:

1. Department of Therapeutic Oncology; Graduate School of Medicine, Kyoto University; Kyoto Japan

2. Department of Health Informatics; School of Public Health in Graduate School of Medicine, Kyoto University; Kyoto Japan

3. Hematology; Graduate School of Medicine, Osaka Metropolitan University; Osaka Japan

4. Department of Heathcare Epidemiology; School of Public Health in the Graduate School of Medicine, Kyoto University; Kyoto Japan

5. Department of Psychiatry; Soseikai General Hospital; Kyoto Japan

Publisher

Wiley

Subject

Pharmacology (medical)

Reference41 articles.

1. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial;Aguado;Clinical Infectious Diseases,2015

2. Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT;Blennow;Bone Marrow Transplant,2010

3. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial;Cordonnier;Clinical Infectious Diseases,2009

4. A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT;Hebart;Bone Marrow Transplant,2009

5. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial;Morrissey;Lancet Infectious Diseases,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coccidioidomycosis and Histoplasmosis in Immunocompetent Individuals: A Comprehensive Review of Clinical Features, Diagnosis, and Management;Cureus;2024-09-01

2. Systematic review on efficacy and safety of empirical versus pre‐emptive antifungal therapy among children with febrile neutropenia reveals paucity of data;Mycoses;2024-04

3. Benefits of early antifungal therapy in hematology patients;Oncohematology;2024-01-27

4. Acute Invasive Pulmonary Aspergillosis: Clinical Presentation and Treatment;Seminars in Respiratory and Critical Care Medicine;2024-01-11

5. Six-year experience with GM test in hematological patients in a public Brazilian tertiary hospital;The Brazilian Journal of Infectious Diseases;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3